Blockage of intermediate-conductance-Ca2+-activated K+ channels inhibits progression of human endometrial cancer

Ahn SC, Seol GH, Kim JA, Suh SH . (2004). Characteristics and a functional implication of Ca2+-activated K+ current in mouse aortic endothelial cells. Pflugers Arch 447: 426–435.

Begenisich T, Nakamoto T, Ovitt CE, Nehrke K, Brugnara C, Alper SL et al. (2004). Physiological roles of the intermediate conductance, Ca2+-activated potassium channel Kcnn4. J Biol Chem 279: 47681–47687.

Chittajallu R, Chen Y, Wang H, Yuan X, Ghiani CA, Heckman T et al. (2002). Regulation of Kv1 subunit expression in oligodendrocyte progenitor cells and their role in G1/S phase progression of the cell cycle. Proc Natl Acad Sci USA 99: 2350–2355.

Dunn PM . (1998). The action of blocking agents applied to the inner face of Ca2+-activated K+ channels from human erythrocytes. J Membr Boil 165: 133–143.

Farias LM, Ocana DB, Diaz L, Larrea F, Avila-Chavez E, Cadena A et al. (2004). Ether a go-go potassium channels as human cervical cancer markers. Cancer Res 64: 6996–7001.

Fraser SP, Grimes JA, Diss JK, Stewart D, Dolly JO, Djamgoz MB . (2003). Predominant expression of Kv1.3 voltage-gated K+ channel subunit in rat prostate cancer cell lines: electrophysiological, pharmacological and molecular characterisation. Pflugers Arch 446: 559–571.

Ghanshani S, Wulff H, Miller MJ, Rohm H, Neben A, Gutman GA et al. (2000). Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J Biol Chem 275: 37137–37149.

Jager H, Dreker T, Buck A, Giehl K, Gress T, Grissmer S . (2004). Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro. Mol Pharmacol 65: 630–638.

Lang F, Henke G, Embark HM, Waldegger S, Palmada M, Bohmer C et al. (2003). Regulation of channels by the serum and glucocorticoid-inducible kinase – implications for transport, excitability and cell proliferation. Cell Physiol Biochem 13: 41–50.

Legrand G, Humez S, Slomianny C, Dewailly E, Vanden Abeele F, Mariot P et al. (2001). Ca2+ pools and cell growth. Evidence for sarcoendoplasmic Ca2+-ATPases 2B involvement in human prostate cancer cell growth control. J Biol Chem 276: 47608–47614.

Levine DA, Hoskins WJ . (2002). Update in the management of endometrial cancer. Cancer J 8: S31–40.

Lu X, Fein A, Feinstein MB, O’Rourke FA . (1999). Antisense knock out of the inositol 1,3,4,5-tetrakisphosphate receptor GAP1(IP4BP) in the human erythroleukemia cell line leads to the appearance of intermediate conductance K(Ca) channels that hyperpolarize the membrane and enhance calcium influx. J Gen Physiol 113: 81–96.

Mork HK, Haug TM, Sand O . (2005). Contribution of different Ca-activated K channels to the first phase of the response to TRH in clonal rat anterior pituitary cells. Acta Physiol Scand 184: 141–150.

Nehrke K, Quinn CC, Begenisich T . (2003). Molecular identification of Ca2+-activated K+ channels in parotid acinar cells. Am J Physiol Cell Physiol 284: C535–C546.

Nilius B, Wohlrab W . (1992). Potassium channels and regulation of proliferation of human melanoma cells. J Physiol 445: 537–548.

Ouadid-Ahidouch H, Chaussade F, Roudbaraki M, Slomianny C, Dewailly E, Delcourt P et al. (2000). KV1.1 K+ channels identification in human breast carcinoma cells: involvement in cell proliferation. Biochem Biophys Res Commun 278: 272–277.

Ouadid-Ahidouch H, Le Bourhis X, Roudbaraki M, Toillon RA, Delcourt P, Prevarskaya N . (2001). Changes in the K+ current-density of MCF-7 cells during progression through the cell cycle: possible involvement of a h-ether.a-gogo K+ channel. Receptors Channels 7: 345–356.

Pardo LA, del Camino D, Sanchez A, Alves F, Bruggemann A, Beckh S et al. (1999). Oncogenic potential of EAG K+ channels. EMBO J 18: 5540–5547.

Parihar AS, Coghlan MJ, Gopalakrishnan M, Shieh CC . (2003). Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation. Eur J Pharmacol 471: 157–164.

Pena TL, Chen SH, Konieczny SF, Rane SG . (2000). Ras/MEK/ERK Up-regulation of the fibroblast KCa channel FIK is a common mechanism for basic fibroblast growth factor and transforming growth factor-beta suppression of myogenesis. J Biol Chem 275: 13677–13682.

Rane SG . (1999). Ion channels as physiological effectors for growth factor receptor and Ras/ERK signaling pathways. Adv Second Messenger Phosphoprotein Res 33: 107–127.

Rane SG . (2000). The growth regulatory fibroblast IK channel is the prominent electrophysiological feature of rat prostatic cancer cells. Biochem Biophys Res Commun 269: 457–463.

Rouzaire-Dubois B, Dubois JM . (1998). K+ channel block-induced mammalian neuroblastoma cell swelling: a possible mechanism to influence proliferation. J Physiol 510 (Part 1): 93–102.

Ryan AJ, Susil B, Jobling TW, Oehler MK . (2005). Endometrial cancer. Cell Tissue Res 322: 53–61.

Schneider JJ, Shroff S, Moser AJ . (2005). Palliative segmental duodenectomy for bleeding, erosive endometrial cancer. Gynecol Oncol 97: 246–248.

Skryma RN, Prevarskaya NB, Dufy-Barbe L, Odessa MF, Audin J, Dufy B . (1997). Potassium conductance in the androgen-sensitive prostate cancer cell line, LNCaP: involvement in cell proliferation. Prostate 33: 112–122.

Smith GA, Tsui HW, Newell EW, Jiang X, Zhu XP, Tsui FW et al. (2002). Functional up-regulation of HERG K+ channels in neoplastic hematopoietic cells. J Biol Chem 277: 18528–18534.

Wang S, Melkoumian Z, Woodfork KA, Cather C, Davidson AG, Wonderlin WF et al. (1998). Evidence for an early G1 ionic event necessary for cell cycle progression and survival in the MCF-7 human breast carcinoma cell line. J Cell Physiol 176: 456–464.

Wang J, Morishima S, Okada Y . (2003). IK channels are involved in the regulatory volume decrease in human epithelial cells. Am J Physiol Cell Physiol 284: C77–C84.

Wonderlin WF, Woodfork KA, Strobl JS . (1995). Changes in membrane potential during the progression of MCF-7 human mammary tumor cells through the cell cycle. J Cell Physiol 165: 177–185.